# Study to Assess the Effects of Allergic Rhinitis and Co-administration of Mometasone or Oxymetazoline on the Pharmacokinetics, Safety, and Tolerability of Intranasal Esketamine

> **NCT02154334** · PHASE1 · COMPLETED · sponsor: **Janssen Research & Development, LLC** · enrollment: 47 (actual)

## Conditions studied

- Allergic Rhinitis

## Interventions

- **DRUG:** Esketamine
- **DRUG:** Mometasone
- **DRUG:** Oxymetazoline

## Key facts

- **NCT ID:** NCT02154334
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2015-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02154334

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02154334, "Study to Assess the Effects of Allergic Rhinitis and Co-administration of Mometasone or Oxymetazoline on the Pharmacokinetics, Safety, and Tolerability of Intranasal Esketamine". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02154334. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*